RxDoctor Payments Data

Arjun Patel, MD

Hospitalist · Camden, NJNPI 1730740473

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,965 of the $6,106 with a category attached, or 64.9%. UOC USA Inc accounts for 65.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $4,748 and has fallen 82.8% since, to $815 in 2025. Among hospitalist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,106in general payments, 2019–2025

Across 37 payments — averaging $165.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UOC USA Inc$4K
  • Kestra Medical Technology Services, Inc.$594
  • Abbott$475
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$325
  • Amgen$180
  • Siemens Medical Solutions USA, Inc.$177
  • plus $365 from 9 others

What the payments were for

  • Consulting fees$3,96565%
  • Food & beverage$1,57526%
  • Education$5669%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,106 in reported general payments places this provider in the 95th percentile of 567 hospitalist providers in New Jersey.

See all hospitalist providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,133
Medicare patients
12
Services billed
12

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lisinopril12$22

Paid to pharmacies, not to this prescriber.

Other hospitalist in Camden

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →